Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins
Research output: Contribution to journal › Journal article › Research › peer-review
Thomas M Bridges, Joy E Marlo, Colleen M Niswender, Carrie K Jones, Satyawan B Jadhav, Patrick R Gentry, Hyekyung C Plumley, C David Weaver, P Jeffrey Conn, Craig W Lindsley
This report describes the discovery and initial characterization of the first positive allosteric modulator of muscarinic acetylcholine receptor subtype 5 (mAChR5 or M5). Functional HTS, identified VU0119498, which displayed micromolar potencies for potentiation of acetylcholine at M1, M3, and M5 receptors in cell-based Ca(2+) mobilization assays. Subsequent optimization led to the discovery of VU0238429, which possessed an EC(50) of approximately 1.16 microM at M5 with >30-fold selectivity versus M1 and M3, with no M2 or M4 potentiator activity.
|Journal||Journal of Medicinal Chemistry|
|Number of pages||4|
|Publication status||Published - 11 Jun 2009|
- Allosteric Regulation/physiology, Animals, CHO Cells, Cricetinae, Cricetulus, Isatin/analogs & derivatives, Mice, Receptor, Muscarinic M5/drug effects